Great post. Yes, the brains in our gut is definitely involved in some crucial functions and competencies. As you’ve pointed out there are numerous factors involved in the operation of the gut and the impact of the gut brain on the head brain. Neuroscience has also uncovered that we have a functional ‘brain’ in our heart. And it’s only when all three brains (head, heart and gut) are aligned, and the autonomic nervous system is in balance, that we make the wisest and most intelligent decisions. Coaching only to the head brain is never enough. We’ve just released a book called ‘mBraining’ (for multiple braining – head, heart and gut) that describes the behavioral modeling research we’ve completed, informed by the recent neuroscience findings, about the core competencies of the three brains, how to communicate with them and how to align them and tap into the innate intelligence of the heart and gut brains. Please check out http:// if you are at all interested in the coaching models we have uncovered in our work.
The adverse effects of corticosteroids in pediatric patients are similar to those in adults (see ADVERSE REACTIONS ). Like adults, pediatric patients should be carefully observed with frequent measurements of blood pressure, weight, height, intraocular pressure, and clinical evaluation for the presence of infection, psychosocial disturbances, thromboembolism, peptic ulcers, cataracts, and osteoporosis. Pediatric patients who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity. This negative impact of corticosteroids on growth has been observed at low systemic doses and in the absence of laboratory evidence of HPA axis suppression (., cosyntropen stimulation and basal cortisol plasma levels). Growth velocity may therefore be a more sensitive indicator of systemic corticosteroid exposure in pediatric patients treated with corticosteroids should be monitored, and the potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of treatment alternatives. In order to minimize the potential growth effects of corticosteroids, pediatric patients should be titrated to the lowest effective dose.
Our current understanding of adrenal function is still at its infancy at best. It is therefore very difficult for any health professional to have a good grasp of the Adrenal Fatigue condition from a purely pathological and physiological perspective. The number of physicians with true expertise in advanced Adrenal Fatigue is very small. Those who are good in this gain their expertise not from textbooks, but from years of clinical experience. There is no short cut, because text-book cases are few and far between. Because the full recovery cycle can take years to complete in severe cases, practitioners with little experience will find it hard to handle cases other than the most mild and straight forward ones.